Cambridge Antibody Tech Group PLC
25 April 2000
Schedule 5 - Block Listing Six-Monthly Return
1 Name of company:
Cambridge Antibody Technology Group plc
2 Name of Scheme:
Cambridge Antibody Technology Share Option Scheme and Staff Share Scheme
3 Period of Return - From:
1 April 1999
To:
31 March 2000
4 Number and class of share(s) (amount of stock/debt security) not issued
under scheme at the end of last period:
1,685,715
10p ordinary shares
5 Number of shares issued/allotted under scheme during period:
449,111
6 Balance under scheme not yet issued/allotted under scheme at end of
period:
1,236,604
7 Number and class of share(s) (amount of stock/debt securities) originally
listed and the date of admission:
22,136,251
10p ordinary shares
25 March 1997
Please confirm total number of shares in issue at the end of the period in
order for us to update our records:
34,275,039 10p ordinary shares
Contact name for queries:
Diane Mellett
Contact telephone number:
01763 263233
Contact address:
CAT Group plc, The Science Park, Melbourn, Cambridgeshire, SG8 6JJ
Name of person making return:
Rowena Gardner
Position of person making return:
Communications Manager
Additional Information:
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.